BRAND: AirFluSal MDI
ACTIVE INGREDIENT: Salmeterol/Fluticasone Propionate
STRENGTH, PACK SIZE & GMS CODES:
AirFluSal MDI 25mcg/125mcg/dose pressurised inhalation, suspension x 1 – GMS Code 16005
AirFluSal MDI 25mcg/250mcg/dose pressurised inhalation, suspension x 1 – GMS Code 16011
Regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate in patients: a) not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting beta-2-agonist or b) already adequately controlled on both inhaled corticosteroids and long acting beta-2-agonist.